Stryker Corporation is launching two new products for spine treatments amid legal troubles for its metal-on-metal hip replacements. The Stryker Venom RF Cannula and Venom Electrode were approved via the same 501(k) method that the recalled Stryker Rejuvenate and Stryker ABG II Modular hip replacements were approved under.
Stryker issued the Rejuvenate and ABG II hip replacement recall after studies showed the devices were causing patients serious injuries. Stryker patients have complained of metal-on-metal hip implant side effects such as fretting, corrosion, tissue damage and metal poisoning.
Stryker faces several Rejuvenate and ABG II lawsuits alleging that the company released a defective device. Stryker hip implant failures have led to patients undergoing revision surgery to correct severe complications related to their hip replacements.